(2-methyl-5-(methylsulfonyl)benzoyl)guanidine Na+/H+ antiporter inhibitors

Journal of Medicinal Chemistry

Volumn 40, Issue 13, 1997, Pages 2017-2034

  Baumgarth, Manfred ^a   Beier, Norbert ^a   Gericke, Rolf ^a  

^a MERCK KGAA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

[2 METHYL 5 (METHYLSULFONYL) 4 PYRROLOBENZOYL]GUANIDINE METHANESULFONATE; ALKYL GROUP; BENZAMIDE DERIVATIVE; BENZOIC ACID DERIVATIVE; CARBOXYLIC ACID; CHLORIDE; GUANIDINE DERIVATIVE; METHYL GROUP; METHYL IODIDE; PALLADIUM; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL CELL; ARTICLE; CHLORINATION; DRUG POTENCY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; METHYLATION; NONHUMAN; PROTON SODIUM EXCHANGE; RABBIT; REDUCTION;

ANIMALS; CRYSTALLOGRAPHY, X-RAY; ERYTHROCYTES; GUANIDINES; MODELS, CHEMICAL; MODELS, MOLECULAR; PROTEIN CONFORMATION; RABBITS; SODIUM; SODIUM-HYDROGEN ANTIPORTER; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONES;

EID: 0030967388     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960768n     Document Type: Article

References (58)

1. (a) Grinstein, S.; Wieczorek, H. Cation antiports of animal plasma membranes. J. Exp. Biol. 1994, 196, 307-318.
2. + exchanger isoforms. Am. J. Physiol. 1995, 268, C283-C296.
3. (c) Yun, C. H.; Tse, C.-M.; Nath, S.; Levine, S. L.; Donowitz, M. Structure/function studies of mammalian Na-H exchangers - an update. J. Physiol. 1995, 482, 1S-6S.
4. + antiport: modulation by ATP and role in cell volume regulation. J. Exp. Biol. 1994, 196, 389-404.
5. + exchange and its inhibition in cardiac ischemia and reperfusion. Basic Res. Cardiol. 1993, 88, 443-455.
6. + exchanger: an update on structure, regulation and cardiac physiology. Biochem. J. 1993, 296, 273-285.
7. + Antiporter Inhibitor on Postischemic Reperfusion in Pig Heart. J. Cardiouasc. Pharmacol. 1994, 23, 72-78.
8. + exchange inhibitor reduces infarct size in pigs. Cardiovasc, Res. 1995, 30, 945-951.
9. + exchanger inhibitors. Am. J. Physiol. 1996, 270, H692-H700.
10. + exchange in ischemia-reperfusion. Basic Res. Cardiol. 1996, 91, 191-202.
11. + exchange inhibitor and its effects in cardiac ischaemia. Br. J. Pharmacol. 1993, 109, 562-568.
12. 2+ Overload in Isolated Perfused Rabbit Heart. Circulation 1994. 89, 2787-2798.
13. + exchange in Human B Lymphoblasts without Influencing Proliferation. Cell. Physiol. Biochem. 1995, 5, 269-275.
14. + Exchange Inhibitor HOE 694. Ann. Thorac. Surg. 1996, 61, 1400-1406.
15. Scholz, W.; Albus, U.; Counillon, L.; Gbgelein, H.; Lang, H.-J.; Linz, W.; Weichert, A.; Scholkens, B. A. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc. Res. 1995, 29, 260-268.
16. Snieckus, V. Directed Ortho Metalation. Tertiary Amide and O-Carbamate Directors in Synthetic Strategies for Polysubstituted Aromatics. Chem. Rev. 1990, 90, 879-933.
17. Mortier, J.; Moyroud, J.; Bennetau, B.; Cain, P. A. The Carboxylic Acid Group as an Effective Director of Ortho-Lithiation. J. Org. Chem. 1994, 59, 4042-4044.
18. Claus, A.; Stapelberg, E. p-Chlor-o-toluylsäure und Derivate. (p-Chloro-o-toluic acid and derivatives.) Liebigs Ann. Chem. 1893, 274, 285-304.
19. Buu-Hoï, N. P.; Xuong, N. D. Carcinogenic Nitrogen Compounds. Part XTV. Friedel-Crafts Reactions with m- and p-Fluorotoluene. J. Chem. Soc. 1953, 386-388.
20. Lancaster Synthesis; Eastgate, White Lund, Morecambe, England.
21. Taylor, E. P.; Watts, G. E. The Friedel-Crafts Acetylation of p-tert.-Butyltoluene. J. Chem. Soc. 1952, 5054.
22. Volkov, R. N.; Zavgorodnii, S. V. A Study of the mechanism of the auto-oxidation of polyalkylbenzenes. Liquid phase autooxidation of isopropyl-o-xylenes. J. Gen. Chem. USSR (Engl. Transl.) 1961, 31, 2454-2459.
23. (a) Gschwend, H. W.; Hillman, M. J. Neue aromatische Dicarbonsäureimide. (Aromatic dicarboxylic acid imides.) Ger. Offen. 2,509,922, 1975; Chem. Abstr. 1976, 84, 74100p.
24. (b) Merchant, J. R.; Deshpande, A. R.; Jadhav, R. G. Rearrangement of the Oximes of 4-Trichloro-4-ethyl-& 4-Trichloro-2,3-dimethyl-2,5-cyclohexadienones. Indian J. Chem., Sect. B 1978, 16, 385-388.
25. Keuning, K. J.; Evenhuis, N. L'acide 2-méthyl-5-bromebenzoïque. (The 2-methyl-5-bromobenzoic acid.) Recl. Chim. Pays-Bas 1935, 54, 73-75.
26. (a) Hayashi, T.; Konishi, M.; Kobori, Y.; Kumada, M.; Higuchi, T.; Hirotsu, K. Dichloro[1,1′-bis(diphenylphosphino)ferrocene]-palladium(II): An Effective Catalyst for Cross-Coupling of Secondary and Primary Alkyl Grignard and Alkylzinc Reagents with Organic Halides. J. Am. Chem. Soc. 1984, 106, 158-163.
27. (b) Tamaru, Y.; Ochiai, H.; Nakamura, T.; Yoshida, Z. Arylation and vinylation of 2-carboethoxyethylzinc iodide and 3-carboethoxypropylzinc iodide catalyzed by palladium. Tetrahedron Lett. 1986, 27, 955-958.
28. (c) Kanai, G.; Miyaura, N.; Suzuki, A. Synthesis of ortho-Acylbenzylboronates via Cross-Coupling Reaction of (Dialkoxyboryl)methylzinc Reagents with Haloarenes. A Stable ortho-Quinodimethane Precursor. Chem. Lett. 1993, 845-848.
29. (d) Weichert, A.; Lang, H.-J.; Scholz, W.; Albus, U.; Lang, F. 3,4,5-Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament. (Preparation of benzoylguanidines as proton-sodium exchange inhibitors.) Eur. Pat. Appl. EP 577,024, 1994; Chem. Abstr. 1994, 120, 244385s.
30. Weichert, A.; Bauer, M.; Wirsig, P. Palladium(0) Catalyzed Cross Coupling Reactions of Hindered, Double Activated Aryl Halides with Organozinc Reagents - The Effect of Copper(I) Cocatalysis. Synlett 1996, 473-474.
31. (a) Simpkins, N. S. Sulphones in Organic Synthesis; Pergamon Press: Oxford, 1993; pp 11-15.
32. (b) Brown, R. W. A Convenient Method for the Preparation of (Alkylsulfonyl)benzoic Acids. J. Org. Chem. 1991, 56, 4974-4976.
33. (c) Feit, P. W.; Tvaermose Nielsen, O. B. Aminobenzoic Acid Diuretics. 8. 3,4-Disubstituted 5-Methylsulfonylbenzoic Acids and Related Compounds. J. Med. Chem. 1976, 19, 402-406.
34. (d) Cragoe, E. J., Jr.; et al., 3-Amino-5-sulfonylbenzoic acids. U.S. Patent 3,953,476, 1976.
35. (e) Englert, H. C.; Lang, H.-J.; Linz, W.; Schölkens, B.; Scholz, W. Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltendes Medikament. (Preparation of benzoylguanidines as antiarrhythmics.) Eur. Pat. Appl. EP 416,499, 1991; Chem. Abstr. 1991, 115, 71158m.
36. Merchant, J. R.; Desai, V. B. Synthesis and Reactions of Some Cyclohexadienones. J. Chem. Soc. 1964, 2258-2261.
37. Jacobsen, O. Ueber die Einwirkung von Schwefelsäure auf Durol und über das dritte Tetramethylbenzol. (On the action of sulfuric acid on durol and on the third tetramethylbenzene.) Chem. Ber. 1886, 19, 1209-1217.
38. Wittig, G.; Hoffmann, R. W. Organic Syntheses; Wiley: New York, 1973; Collect. Vol. V, pp 60-66.
39. Miyaura, N.; Yanagi, T.; Suzuki, A. The palladium-catalyzed cross-coupling reaction of phenylboronic acid with haloarenes in the presence of bases. Synth. Commun. 1981, 11, 513-519.
40. (a) Echavarren, A. M.; Stille, J. K. Palladium-catalyzed coupling of aryl triflates with organostannanes. J. Am. Chem. Soc. 1987, 109, 5478-5486.
41. (b) Alvarez, A.; Guzmán, A.; Ruiz, A.; Velarde, E.; Muchowski, J. M. Synthesis of 3-Arylpyrroles and 3-Pyrrolylacetylenes by Palladium Catalyzed Coupling Reactions. J. Org. Chem. 1992, 57, 1653-1656.
42. Davidson, R. I. Trifluoromethylation process. U.S. Patent 4,814,482, 1989.
43. Hayakawa, I; Hiramitsu, T; Tanaka, Y. Synthesis and Antibacterial Activities of Substituted 7-Oxo-2,3-dihydro-7H-pyrido-[1,2,3-de][1,4]benzoxazine-6-carboxylic Acids. Chem. Pharm. Bull. 1984, 32, 4907-4913.
44. Mukaiyama, T. New synthetic methods. New syntheses with onium salts of azaarenes. Angew. Chem., Int. Ed. Engl. 1979, 18, 707-721.
45. Lerch, A.; Popelak, A.; Thiel, M.; Schaumann, W.; Hardebeck, K. Neue 4-Alkyl-5-alkylsulfonyl-amino-benzoesäure-Derivate. (Diuretic 4-alkyl-5-(alkylsulfonyl)aminobenzoic acid derivatives.) Ger. Offen. 2,237,115, 1974; Chem. Abstr. 1974, 80, 120566n.
46. Lang, H.-J.; Weichert, A.; Kleemann, H.-W.; Englert, H.; Scholz, W.; Albus, U. Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika. (Preparation of benzoylguanidines as drugs, e.g., antiarrhythmic agents.) Eur. Pat. Appl. EP 589,336, 1994; Chem. Abstr. 1994, 121, 300597x.
47. Lang, H.-J.; Kleemann, H.-W.; Scholz, W.; Albus, U. Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikuro sowie sie enthaltendes Medikament. (Substituted benzoylguanidine cardiovascular and cardioprotective agents.) Eur. Pat. Appl. EP 602,523, 1994; Chem. Abstr. 1994, 121, 157533r.
48. Lang, H.-J.; Weichert, A.; Englert, H.; Scholz, W.; Albus, U.; Lang, F. Ortho-substituierte Benzoylguanidine, zur Behandlung und zur Prophylaxe von Herz-Rhythmus-Störungen und von ischämiach induzierten Schäden sowie zur Inhibition der Proliferation von Zellen. (Preparation of 3-(substituted sulfo)-benzoylguanidines as antiarrhythmics, antiischemics, and cell proliferation inhibitors.) Eur. Pat. Appl. EP 556,673, 1993; Chem. Abstr. 1994, 120, 8337g.
49. Renga, J. M.; Wang, P.-C. Trimethylsilyl trichloroacetate: A new reagent for salt-free silylations. Tetrahedron Lett. 1985, 26, 1175-1178.
50. + antiport in rabbit erythrocytes: two distinct transport systems. J. Membrane Biol. 1991, 120, 41-49.
51. + exchange of rabbit red cells: Evidence for a common pathway. J. Membrane Biol. 1990, 118, 193-214.
52. + uptake assay still appears to be valid.
53. Unpublished results.
54. Viswanadhan, V. N.; Ghose, A. K.; Revankar, G. R.; Robins, R. K. Atomic Physicochemical Parameters for Three Dimensional Structure Directed Quantitative Structure-Activity Relationships. 4. Additional Parameters for Hydrophobic and Dispersive Interactions and Their Application for an Automated Superposition of Certain Naturally Occurring Nucleoside Antibiotics. J. Chem. Inf. Comput. Sci. 1989, 29, 163-172.
55. 2+ concentrations. Thus, the cardioprotective effects of a NHE-1 inhibition occur by a functional targeting rather than by generating a cardiac specific inhibitor.
56. + Antiporter Isoforms Using Amiloride Analogs and a New Inhibitor Exhibiting Anti-ischemic Properties. Mol. Pharmacol. 1993, 44, 1041-1045.
57. To be published elsewhere.
58. + exchange in platelets of patients with essential hypertension using an optical swelling assay. J. Hypertens. 1991, 9, 231-238.